Investegate |Indivior PLC Announcements | Indivior PLC: Indivior To Acquire Opiant Pharmaceuticals
Investegate announcements from Indivior PLC, Indivior To Acquire Opiant Pharmaceuticals
Source: investegate.co.uk
📰 Second Full Year News
Second Full Year News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Second Full Year. Real-time updates on events, politics, business and more.
Indivior To Acquire Opiant Pharmaceuticals
/PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") and Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) ("Opiant") today announced that the...
United States Mark Crossley Kathryn Hudson Centers For Disease Development Agency National Institute On Drug Abuse
Source: prnewswire.com
Breast and Prostate Cancer Diagnoses Still Lagging During Second Full Year of COVID-19 Pandemic, Quest Diagnostics Health Trends® Study Finds
/PRNewswire/ -- More than two years after the COVID-19 pandemic began, diagnoses of breast and prostate cancer, two of the nations leading causes of cancer...
United States Harveyw Kaufman Yuri Fesko Fitch Ratings American Society Of Clinical Oncology National Institutes Of Cancer
Source: prnewswire.com
Breast and Prostate Cancer Diagnoses Still Lagging During Second Full Year of COVID-19 Pandemic, Quest Diagnostics Health Trends® Study Finds
/PRNewswire/ -- More than two years after the COVID-19 pandemic began, diagnoses of breast and prostate cancer, two of the nations leading causes of cancer...
United States Harveyw Kaufman Yuri Fesko Fitch Ratings American Society Of Clinical Oncology National Institutes Of Cancer
Source: prnewswire.com